Search for: "Lupin Pharmaceuticals"
Results 41 - 60
of 175
Sorted by Relevance
|
Sort by Date
18 Jan 2024, 9:16 am
Additionally, Lupin Ltd. and Lupin Pharmaceuticals, Inc. [read post]
14 Jan 2024, 9:29 pm
Lupin Ltd. [read post]
1 May 2011, 2:02 pm
Lupin, concerning patent term extensions. [read post]
23 Dec 2012, 11:00 am
In an earlier post (here) we had blogged about the National Pharmaceutical Policy 2011 and its essential features. [read post]
17 Oct 2007, 10:00 pm
I have just found out from the Generic Pharmaceuticals and IP blog that Teva has now sued 16 companies in relation to its Carvedilol process patents.The 16 defendants are: Zentiva; Mylan; Taro Pharmaceuticals; Lupin; Moehs Iberica; Urquima; Orchid; Wanbury;Z hejiang Huahai; USV Ltd.; Cadila; Ranbaxy; Dr. [read post]
20 Dec 2012, 8:44 am
Lupin Limited, et al., C.A. [read post]
2 Jan 2024, 8:45 pm
Lupin Ltd. [read post]
8 Sep 2008, 4:36 am
Teva Pharmaceutical... [read post]
17 Sep 2007, 2:00 pm
Lupin, Ltd. (06-1530). [read post]
24 Dec 2008, 9:04 am
After Lupin, Dr. [read post]
9 Jun 2008, 4:50 am
Lupin Limited et al. v. [read post]
16 Jun 2008, 10:00 am
I've previously blogged about Lupin's successful development, patenting and sale of its Coversyl IP porfolio to Servier (see Pharmaceutical Lifecycle Management & IP acquisitions). [read post]
22 Oct 2007, 10:00 pm
The recent study which I undertook on pharmaceutical lifecycle management yielded some interesting findings apart from decreasing periods of monopoly and earlier patent filings by non-innovators (both of which I have previously written about). [read post]
21 Nov 2012, 11:32 am
Lupin Ltd., C.A. [read post]
12 Sep 2012, 2:41 am
Salix Pharmaceuticals and Dr. [read post]
26 May 2008, 9:11 pm
King Pharmaceuticals markets Altace (ramipril), which is indicated for the treatment of high blood pressure. [read post]
1 Jun 2018, 7:21 am
" Endo Pharmaceuticals Inc. v. [read post]
7 Jan 2024, 9:59 pm
Lupin Ltd. [read post]
6 Nov 2007, 9:57 pm
In 2005, Lupin Pharmaceuticals submitted the second ANDA with a paragraph IV certification to the '722 patent. [read post]
